Cyteir Therapeutics Company Profile, Contacts & Intelligence
Research Services128 Spring St, Building a2 employeesFounded 2012
Employees
2
Company source estimate
Cyteir Therapeutics Overview
Cyteir was a clinical-stage oncology company focused on the development of CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters. Cyteir had CYT-0851 in development in combination with capecitabine and gemcitabine in a Phase 1/2 clinical study, including patients with advanced ovarian cancer.
- Headquarters
- 128 Spring St, Building a
- Website
- cyteir.com
- Industry
- Research Services
- Founded
- 2012
- NAICS
- Scientific Research and Development Services, Research and Development in the Physical, Engineering, and Life Sciences
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
Cyteir Therapeutics Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Cyteir Therapeutics People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Compare Similar Companies to Cyteir Therapeutics
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Kymera Therapeutics | Biotechnology Research | 250 | View company |
| Editas Medicine | Biotechnology Research | 232 | View company |
| Cabaletta Bio | Biotechnology Research | 176 | View company |
| C4 Therapeutics, Inc. | Biotechnology | 123 | View company |
| Alkeus Pharmaceuticals, Inc. | Biotechnology Research | 77 | View company |
| Kelonia Therapeutics | Biotechnology | 65 | View company |
| LifeMine Therapeutics | Biotechnology | 54 | View company |
| Crossbow Therapeutics, Inc | Biotechnology Research | 41 | View company |
| Scorpion Therapeutics | Biotechnology Research | 35 | View company |
| Monomoy Advisors | Business Consulting And Services | 16 | View company |